Application Data
(The purity of this product is >95% as determined by SEC-HPLC.)
anti-General Dinutuximab Monoclonal Antibody
Research Grade Dinutuximab
Reactivity
General
Purity
>95% by SDS-PAGE; Protein A or G purified from cell culture supernatant.
Synonyms
Dinutuximab, Antibody; Research Grade Dinutuximab; 14.18; MAb-14.18; MOAB Ch14.18; CAS: 1363687-32-4; anti-Dinutuximab antibody
Reactivity
General
Clonality
Monoclonal
Isotype
IgG1-kappa
Clone Number
Dinutuximab
Purity/Purification
>95% by SDS-PAGE; Protein A or G purified from cell culture supernatant.
Form/Format
Liquid; 0.01M PBS, pH 7.4
Concentration
4 mg/ml (varies by lot)
Host Species
Chimeric
CAS
65988-71-8
Target
Ganglioside GD2
Dry Ice Shipment
Extra charge fee may add to your shipping cost as dry ice is required to ship this product.
Preparation and Storage
Store at 4 degree C short term (1-2 weeks).
Store at -20 degree C for 12 months.
Store at -80 degree C long term.
Use a manual defrost freezer and avoid repeated freeze-thaw cycles
Store at -20 degree C for 12 months.
Store at -80 degree C long term.
Use a manual defrost freezer and avoid repeated freeze-thaw cycles
Application Data
(The purity of this product is >95% as determined by SEC-HPLC.)
Application Data
(The purity of this product is >95% as determined by SEC-HPLC.)
SDS-PAGE
(SDS PAGE for Dinutuximab)
SDS-PAGE
(SDS PAGE for Dinutuximab)
Product Categories/Family for anti-Dinutuximab antibody
References
Dinutuximab, PMID: 29999821
Dinutuximab, PMID: 31644006
Irinotecan-temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial, PMID: 28549783
The safety of dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma, PMID: 30433831
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial, PMID: 30442501
Dinutuximab, PMID: 31644006
Irinotecan-temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial, PMID: 28549783
The safety of dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma, PMID: 30433831
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial, PMID: 30442501
Similar Products
Product Notes
The Dinutuximab (Catalog #AAA119955) is an Antibody and is intended for research purposes only. The product is available for immediate purchase. The Research Grade Dinutuximab reacts with General and may cross-react with other species as described in the data sheet. It is sometimes possible for the material contained within the vial of "Dinutuximab, Monoclonal Antibody" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.Precautions
All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.Disclaimer
Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.Item has been added to Shopping Cart
If you are ready to order, navigate to Shopping Cart and get ready to checkout.